checkAd
    Startseite > Aktien > Sensei Biotherapeutics > Nachrichten
    Sensei Biotherapeutics Aktie
    1,8400
     
    USD
    +1,66 %
    +0,0300 USD
    Letzter Kurs 02:00:00 Nasdaq
    1,8300
     
    USD
    100 STK
    Geldkurs 08.05.24
    1,8400
     
    USD
    700 STK
    Briefkurs 08.05.24
    ISIN: US81728A1088 · WKN: A2QM6J · SYM: SNSE · USA

    Neueste Nachrichten

    Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
    24.04.24 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference
    09.04.24 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment
    04.04.24 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
    22.03.24 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences
    06.03.24 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
    28.02.24 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics to Present at Upcoming Conferences
    07.02.24 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
    04.01.24 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
    07.11.23 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting
    03.11.23 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer
    01.11.23 · globenewswire · Sensei Biotherapeutics
    Sensei Biotherapeutics to Present Initial Clinical Data from Dose Escalation Trial of SNS-101 at 2023 SITC Annual Meeting
    25.10.23 · globenewswire · Sensei Biotherapeutics